메뉴 건너뛰기




Volumn 31, Issue 8, 2010, Pages 867-868

Increase in use of vancomycin for Clostridium difficile infection in us hospitals

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

EID: 77955914569     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/655442     Document Type: Article
Times cited : (6)

References (8)
  • 1
    • 28844494086 scopus 로고    scopus 로고
    • An epidemic, toxin gene- variant strain of Clostridium difficile
    • McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene- variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-2441.
    • (2005) N Engl J Med , vol.353 , pp. 2433-2441
    • McDonald, L.C.1    Killgore, G.E.2    Thompson, A.3
  • 2
    • 43249096532 scopus 로고    scopus 로고
    • The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection
    • Bartlett JG. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Clin Infect Dis 2008;46:1489-1492.
    • (2008) Clin Infect Dis , vol.46 , pp. 1489-1492
    • Bartlett, J.G.1
  • 4
    • 46249099130 scopus 로고    scopus 로고
    • Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile- associated disease
    • Al-Nassir WA, Sethi AK, Li Y, Pultz MJ, Riggs MM, Donskey CJ. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile- associated disease. Antimicrob Agents Chemother 2008;52:2403-2406.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2403-2406
    • Al-Nassir, W.A.1    Sethi, A.K.2    Li, Y.3    Pultz, M.J.4    Riggs, M.M.5    Donskey, C.J.6
  • 5
    • 34547133720 scopus 로고    scopus 로고
    • A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile- associated diarrhea, stratified by disease severity
    • Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile- associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45: 302-307.
    • (2007) Clin Infect Dis , vol.45 , pp. 302-307
    • Zar, F.A.1    Bakkanagari, S.R.2    Moorthi, K.M.3    Davis, M.B.4
  • 6
    • 43249103183 scopus 로고    scopus 로고
    • Vancomycin for the treatment of Clostridium difficile infection: For whom is this expensive bullet really magic?
    • Pepin J. Vancomycin for the treatment of Clostridium difficile infection: for whom is this expensive bullet really magic? Clin Infect Dis 2008;46: 1493-1498.
    • (2008) Clin Infect Dis , vol.46 , pp. 1493-1498
    • Pepin, J.1
  • 7
    • 19344364596 scopus 로고    scopus 로고
    • Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
    • Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-1590.
    • (2005) Clin Infect Dis , vol.40 , pp. 1586-1590
    • Musher, D.M.1    Aslam, S.2    Logan, N.3
  • 8
    • 71949119436 scopus 로고    scopus 로고
    • Using international classification of diseases, 9th edition, Clinical Modification codes and drug utilization data to identify hospital acquired Clostridium difficile infection
    • Schmiedeskamp M, Harpe SE, Polk RE, Oinonen M, Pakyz AL. Using International Classification of Diseases, 9th Edition, Clinical Modification codes and drug utilization data to identify hospital acquired Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:1070-1076.
    • (2009) Infect Control Hosp Epidemiol , vol.30 , pp. 1070-1076
    • Schmiedeskamp, M.1    Harpe, S.E.2    Polk, R.E.3    Oinonen, M.4    Pakyz, A.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.